Latest news
Debiopharm Group™ moves forward three of its oncology clinical programs and will present the recent progresses at the 50th American…
Orient EuroPharma and Debiopharm Group™ announce their partnership and the launch of Pamorelin LA in Singapore
Evotec and Debiopharm Group™ to collaborate on development of new treatment for cancer
Curis and Debiopharm Group™ Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014
Debiopharm Group™ to Acquire Products or Companies to Expand Activities at Manufacturing Facility in Martigny (Valais, Switzerland)
Debiopharm Group™ and Yale University extend and broaden their collaboration for the discovery and development of MIF inhibitors to treat…
Debiopharm Group™ to Acquire Affinium’s Antibiotic Clinical Assets and Platform to Identify and Develop Targeted Antibiotics
Debiopharm Group™ Announces Completion of Recruitment for Phase III Clinical Study with Triptorelin 22.5 mg in Central Precocious Puberty